Results 11 to 20 of about 13,217 (287)

RANK-Ligand inhibitor associated osteonecrosis of the jaw

GMS Interdisciplinary Plastic and Reconstructive Surgery DGPW, 2013
Osteonecrosis of the jaw may be caused by many different triggers. One of them is described to be the drug or medication related osteonecrosis of the jaw. Since many years bisphosphonates induced the dreaded diagnosis.
Rashad, Ashkan, Smeets, Ralf, Heiland, Max   +2 more
doaj   +2 more sources

Intraosseous Squamous Cell Carcinoma Associated with Denosumab-Induced Osteonecrosis of the Jaw

Applied Sciences, 2021
Medication-related osteonecrosis of the jaw (MRONJ) has been associated with the use of different drugs administered in the treatment of malignant neoplasms or metastases and in antiresorptive therapies. Since 2010, denosumab, a monoclonal antibody whose
Sandra Bacián Martínez, Carlos Navarro Cuéllar, Carlos Navarro Vila, Edurne Palacios Weiss, Roser Pujol Romanyá, Álvaro del Amo Fernández de Velasco, Margarita Escrig de Teijeiro, José Luis del Castillo Pardo de Vera, Irene Rodríguez Pérez, Arturo Sánchez-Pérez, José J. Zamorano-León, Antonio López-Farré, María Isabel García-Hidalgo Alonso, Ignacio Navarro Cuéllar   +13 more
doaj   +3 more sources

The Validity of Claims-Based Algorithms to Identify Serious Hypersensitivity Reactions and Osteonecrosis of the Jaw. [PDF]

PLoS ONE, 2015
Validation of claims-based algorithms to identify serious hypersensitivity reactions and osteonecrosis of the jaw has not been performed in large osteoporosis populations.
Nicole C Wright, Jeffrey R Curtis, Tarun Arora, Wilson K Smith, Meredith L Kilgore, Kenneth G Saag, Monika M Safford, Elizabeth S Delzell   +7 more
doaj   +2 more sources

CYP2C8 gene polymorphism and bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma

Haematologica, 2011
Osteonecrosis of the jaw is an uncommon but potentially serious complication of bisphosphonate therapy in multiple myeloma. Previous studies showed that the presence of one or two minor alleles of the cytochrome P450, subfamily 2C polypeptide 8 gene ...
Esperanza Such, José Cervera, Evangelos Terpos, José V Bagán, Amparo Avaria, Inés Gómez, María Margaix, Mariam Ibañez, Irene Luna, Lourdes Cordón, Mónica Roig, Miguel A. Sanz, Meletios A. Dimopoulos, Javier de la Rubia   +13 more
doaj   +2 more sources

Antiresorptive agent-related osteonecrosis of the jaw: Position Paper 2017 of the Japanese Allied Committee on Osteonecrosis of the Jaw

Journal of Bone and Mineral Metabolism, 2016
Antiresorptive agent-related osteonecrosis of the jaw (ARONJ) is an intractable, though rare, complication in cancer patients with bone metastases and patients with osteoporosis who are treated with antiresorptive agents, including bisphosphonates and ...
T. Yoneda, H. Hagino, T. Sugimoto, H. Ohta, S. Takahashi, S. Soen, A. Taguchi, T. Nagata, M. Urade, T. Shibahara, S. Toyosawa, Japanese Allied Committee on Osteonecrosis of the Jaw   +11 more
semanticscholar   +2 more sources

Bisphosphonate-Related Osteonecrosis of the Jaw Mimicking Bone Metastasis [PDF]

Case Reports in Oncological Medicine, 2014
Osteonecrosis of the jaw is usually a potential complication of bisphosphonate therapy. In a cancer patient, this disease entity can be misdiagnosed as a metastatic lesion. Our aim is to make clinicians aware of bisphosphonate associated osteonecrosis of
Geetika Bhatt, Aashish Bhatt, Anthony E. Dragun, Xiao-Feng Li, A. Cahid Civelek   +4 more
doaj   +2 more sources

The Use of Imaging Methods in the Diagnosis of Bisphosphonate-related Osteonecrosis of the Jaw

Česká Stomatologie a Praktické Zubní Lékařství, 2012
Objectives: Osteonecrosis of the jaws is a rare side effect of bisphosphonate therapy, occurring especially in oncological patients but also in patients with metabolic bone diseases.
L. Hauer, J. Baxa, D. Hrušák, L. Hostička, P. Andrle   +4 more
doaj   +2 more sources

Prediction of medication-related osteonecrosis of the jaw (MRONJ) using automated machine learning in patients with osteoporosis associated with dental extraction and implantation: a retrospective study

Journal of the Korean Association of Oral and Maxillofacial Surgeons, 2023
Objectives This study aimed to develop and validate machine learning (ML) models using H2O-AutoML, an automated ML program, for predicting medication-related osteonecrosis of the jaw (MRONJ) in patients with osteoporosis undergoing tooth extraction or ...
Dahui Kwack, Sung Min Park
semanticscholar   +1 more source

Medication-related osteonecrosis of the jaw: A disease of significant importance for older patients.

Journal of The American Geriatrics Society, 2023
BACKGROUND Medication-related osteonecrosis of the jaw (MRONJ) is clinically defined as a non-healing jawbone ulcerative-necrotic lesion appearing after dental therapy or minor trauma in patients treated previously with anti-resorptive, anti-angiogenic ...
Bridget Boston, D. Ipe, B. Căpitănescu, A. Gresita, S. Hamlet, R. Love, M. Hadjiargyrou, Chien-Ling Huang, I. Nusem, R. Miroiu, A. Popa-Wagner, P. Warnke, E. Petcu   +12 more
semanticscholar   +1 more source

Iatrogenic risk of osteonecrosis of the jaw? Bone substitutes for dental implants: a warning from Japan [PDF]

, 2020
2020-02Commercial bone substitutes that are widely used for bone augmentation for dental implants are predisposing factors in the development of osteonecrosis of the jaw (ONJ), overlooking this situation may lead to serious problems.
Hibi, Hideharu
core   +1 more source